Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.46 CAD
Change Today -0.03 / -6.19%
Volume 2.7M
TST On Other Exchanges
TST is not on other exchanges.
As of 3:59 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Berendt Ph.D.

Chief Executive Officer, Chief Scientist and Director,Telesta Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 42 board members in 7 different organizations across 14 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael J. Berendt, Ph.D., has been the Chief Executive Officer at Bioniche Life Sciences Inc. since November 4, 2013 and has been its Chief Scientist Officer since November 2013. Dr. Berendt served as the Chief Executive Officer and President of Aegera Therapeutics, Inc., since January 14, 2007 until 2011. Dr. Berendt served as the Managing Director of AEA Investors LP. He served as a Consultant of Bioniche Life Sciences Inc. From November 2000 to August 2004, he ...

Read Full Background

Corporate Headquarters*

231 Dundas Street East
Belleville, Ontario K8N 1E2


Phone: 613-966-8058
Fax: 613-966-4177

Board Members Memberships*

Interim Chairman and Chairman of Compensation Committee
Independent Director and Chairman of Nominating & Corporate Governance Committee
Director and Chairman of Nominating & Corporate Governance Committee
Chief Executive Officer, Chief Scientist and Director


Miami University
Unknown/Other Education
Ohio Dominican College
Hahnemann University Medical School

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$256,272

Stock Options*

All Other CompensationC$53,231

Total Compensation*

Total Annual Cash CompensationC$434,482
Total Short Term CompensationC$256,272
Other Long Term CompensationC$53,231
Total Calculated CompensationC$1,430,782
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TST:CN C$0.46 CAD -0.03


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELESTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at